Found 176 chains in Genus chains table. Displaying 1 - 50. Applied filters: Proteins

Search results query: mitogen-activated protein kinase 1

Total Genus Sequence Length pdb Title
111 351 6rfpA Erk2 map kinase with mutations at helix-g
107 339 6rq4A Inhibitor of erk2
112 339 6slgA Human erk2 with erk1/2 inhibitor, azd0364.
110 349 6opgA Phosphorylated erk2 with amp-pnp
89 347 6opiA Phosphorylated erk2 with sch-cpd336
115 347 6nbsA Wt erk2 with compound 2507-8
113 346 6opkA Phosphorylated erk2 with vertex-11e
113 348 6ophA Phosphorylated erk2 with gdc-0994
109 348 6ot6A Rat erk2 d319n
88 350 6otsA Rat erk2 e320k
97 345 6d5yA Crystal structure of erk2 g169d mutant
100 347 6dmgA A multiconformer ligand model of ek6 bound to erk2
116 346 6flvA Crystal structure of erk2 in complex with an adenosine derivative
110 348 6gjdA Erk2 signalling protein
115 346 6fmaA Crystal structure of erk2 in complex with an adenosine derivative
111 346 6fr1A Crystal structure of erk2 in complex with an adenosine derivative
116 346 6frpA Crystal structure of erk2 in complex with an adenosine derivative
108 345 6fleA Crystal structure of erk2 in complex with an adenosine derivative
116 345 6fj0A Crystal structure of erk2 in complex with an adenosine derivative
112 346 6fjbA Crystal structure of erk2 in complex with an adenosine derivative
118 347 6g54A Crystal structure of erk2 covalently bound to sm1-71
116 346 6fq7A Crystal structure of erk2 in complex with an adenosine derivative
112 350 6gjbA Erk2 signalling protein
111 346 6fn5A Crystal structure of erk2 in complex with an adenosine derivative
108 346 6fi6A Crystal structure of erk2 in complex with an adenosine derivative
119 345 6fi3A Crystal structure of erk2 in complex with an adenosine derivative
117 346 6fjzA Crystal structure of erk2 in complex with an adenosine derivative
108 348 6qa1A Erk2 mini-fragment binding
110 350 6qa3A Erk2 mini-fragment binding
106 347 6qawA Erk2 mini-fragment binding
106 347 6qa4A Erk2 mini-fragment binding
109 347 6qagA Erk2 mini-fragment binding
113 346 6q7sA Erk2 mini-fragment binding
109 350 6q7kA Erk2 mini-fragment binding
115 347 6qaqA Erk2 mini-fragment binding
106 347 6qalA Erk2 mini-fragment binding
107 347 6qahA Erk2 mini-fragment binding
113 346 6q7tA Erk2 mini-fragment binding
106 346 6fxvA Crystal structure of erk2 in complex with an adenosine derivative
107 357 3sa0A Complex of erk2 with norathyriol
110 345 5nhlA Human erk2 with an erk1/2 inhibitor
109 345 5nhvA Human erk2 with an erk1/2 inhibitor
116 348 5nhhA Human erk2 with an erk1/2 inhibitor
112 347 5lcjA In-gel activity-based protein profiling of a clickable covalent erk 1/2 inhibitor
116 350 5k4iA Crystal structure of erk2 in complex with compound 22
117 347 5hd4A Dissecting therapeutic resistance to erk inhibition rat wild type sch772984 in complex with (3r)-1-(2-oxo-2-{4-[4-(pyrimidin-2-yl)phenyl]piperazin-1-yl}ethyl)-n-[3-(pyridin-4-yl)-2h-indazol-5-yl]pyrrolidine-3-carboxamide
107 348 6gdqA Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of erk1/2
107 347 6g9kA Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of erk1/2
108 347 6ge0A Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of erk1/2
109 350 6g9aA Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of erk1/2